Kewaunee Scientific Corporation · NASDAQ:KEQU
Kewaunee Scientific — Q1 FY2027 Earnings Presentation
20 slides from Kewaunee Scientific's earnings presentation, September 2026
Slide 1: Kewaunee Scientific Corporation
KEWAUNEE SCIENTIFIC CORPORATION NASDAQ: KEQU
Slide 2: Special Note Regarding Forward-Looking Statements
Special Note Regarding Forward-Looking Statements Certain statements in this document constitute "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Reform Act"). All statements other than statements of historical fact included in this Annual
Slide 3: About Non-GAAP Measures
About Non-GAAP Measures The following slides include non-GAAP financial measures such as adjusted net earnings and adjusted net earnings per share as supplemental information relating to Kewaunee’s operating results. Adjusted net earnings represent GAAP net earnings adjusted for professional and oth
Slide 4: Company Overview
Founded 1906 120+ years of experience Statesville, NC Global Headquarters Statesville, NC Plymouth, MN Bangalore, India Manufacturing Locations India Spain Singapore Saudi Arabia International Sales Offices Largest laboratory furniture manufacturer in the world. Kewaunee is the only manufacturer to
Slide 5: Serving Customers Worldwide
Serving Customers Headquarters Worldwide ▪ Statesville, NC Manufacturing Locations ▪ Statesville, NC ▪ Bangalore, India Sales Locations ▪ India ▪ Spain ▪ Singapore ▪ Saudi Arabia Headquarters & Manufacturing ▪ Plymouth, MN Warehouse Partnership ▪ The Netherlands OEM Partnerships ▪ China
Slide 6: Robust, Diverse End Markets
Robust, Diverse End Markets We believe in empowering the scientific community with spaces that inspire, innovate, and integrate. Serving the forefront of life sciences, education, healthcare, industrial, petrochemical, and government research, we deliver unparalleled laboratory environments tailored
Slide 7: What Sets Us Apart
WHAT SETS US APART Experience Serving Users in Multiple End-Use Markets KEWAUNEE 01 The industries served by Kewaunee continue to invest in research and development, requiring Kewaunee products in diverse markets. SCIENTIFIC Industry-Leading Portfolio CORPORATION 02 Kewaunee offers total lab solutio
Slide 8: 5 Years of Transformational Growth & Profitability Expansion
5 Years of Transformational Growth & Profitability Expansion Revenue increased 91% while EBITDA grew more than 112x, demonstrating the strength of Kewaunee’s operating model & strategic execution. REVENUE NEARLY DOUBLED EBITDA INCREASED MORE THAN 112X TRANSFORMATIONAL VALUE CREATION ▪ Revenue scale
Slide 9: Introducing Kewaunee's Lab Products Group
Introducing The formation of the Lab Products Group (LPG) brings together Kewaunee Kewaunee’s Lab Scientific, NuAire, and EVERHUTCH into one integrated platform that expands scope, increases potential revenue per project, and strengthens customer relationships. This structure improves efficiency, dr
Slide 10: Global Leader in Laboratory Infrastructure & Solutions
FOUNDED GLOBAL LEADER IN LABORATORY INFRASTRUCTURE & SOLUTIONS 1906 Designing Safe, Efficient, and Innovative Lab Environments 120+ YEARS OF INNOVATION COMPANY OVERVIEW KEY PRODUCTS & SOLUTIONS Leading manufacturer of laboratory furniture, infrastructure, and integrated workspace solutions. For KEMR
Slide 11: Global Leader in Biosafety and Containment Control
FOUNDED GLOBAL LEADER IN BIOSAFETY AND CONTAINMENT CONTROL 1971 Protecting People, Product, and Environment 60+ YEARS OF INNOVATION COMPANY OVERVIEW KEY PRODUCTS & SOLUTIONS Leading designer and manufacturer of laboratory BIOSAFETY LAMINAR AIRFLOW VENTILATED RESTRICTED ACCESS equipment focused on bi
Slide 12: Financial Review
Financial Review
Slide 13: Historical Financials
Historical Financials Kewaunee Scientific Corporation | NASDAQ: KEQU Consistent Revenue and Backlog Stable Annual Revenue Globally Revenue Backlog LPG International $214.9M $282.0M $179.4M $240.5M $214.6M $203.8M $137.3M $165.9M $155.6M $66.5M $67.1M $61.1M FY2024 FY2025 FY2026 FY2024 FY2025 FY2026
Slide 14: FY26 Financial Review
FY26 Financial Review Professional $ in thousands, excluding FY24 FY25 FY26 FY26 per share data & Other Adjusted Adjusted Reported Adjusted Fees1 Net Sales $203,755 $240,472 $281,999 $- $281,999 Operating Profit 18,281 23,477 16,715 785 17,500 % of Sales 9.0% 9.8% 5.9% 0.0% 6.2% Pension, Interest an
Slide 15: First Quarter, QTD FY2027
First Quarter, QTD FY2027 Revenue Net Earnings Diluted EPS $71.1 $1.04 $66.3 $3.1M $0.58 $1.7M FY26 Q1 FY27 Q1 FY26 Q1 FY27 Q1 FY26 Q1 FY27 Q1 15
Slide 16: Balance Sheet
Balance Sheet ($000's) As of July 31, 2026 As of April 30, 2026 As of April 30, 2025 Cash, Cash Equivalents & Restricted $10,261 $11,617 $17,164 Cash Total Assets $175,800 $178,311 $194,654 Total Liabilities $98,580 $101,499 $128,409 Total Stockholders' Equity $77,220 $76,812 $66,245 Total Liabiliti
Slide 17: Strategic Direction and Outlook
Strategic Direction and Outlook
Slide 18: Strategic Direction and Outlook
Strategic Direction and Outlook OUR GUIDING PRINCIPLES 01 02 03 04 We will be easy to do We will get closer to We will do everything We will lead and not business with. our customer(s). with excellence. follow (we are innovators). 18
Slide 19: Capital Allocation Philosophy
Capital Allocation Philosophy We believe that disciplined and thoughtful capital allocation is essential to the long-term health and success of our business. Following our acquisition of NuAire, we now operate three strong, market-leading businesses, each well-positioned to generate sustained cash f
Slide 20: A Trusted Partner for the Next Chapter
A Trusted Partner for the Next Chapter Kewaunee as a Succession Solution Legacy matters at Kewaunee. With nearly 120 years of continuous operation, we’ve built a reputation on trust, reliability, and lasting relationships. As a publicly traded company with strong governance and a disciplined operati
Kewaunee Scientific — Q1 FY2027 Earnings Presentation on 6ix